Skip to main

Annual survey

We would appreciate it if you could complete our website survey, open until 28 November 2025.

Designation of Blinatumomab as an orphan drug - Amgen Australia Pty Ltd

This item is authorised by the following title:

Latest version
C2013G0176127 November 2013

Legislation text